examined CD38 expression levels in AML cell lines (n=9) and AML patient cells (n=10) (38), and confirmed that CD38 expression significantly differed between AML cell lines (12,827 ± 19,320 molecules/cell) and AML primary cells (11,560 ± 8,175 molecules/cell). Here, CD38 is linked to acute myeloid leukemia.